A novel high-affinity human monoclonal antibody to mesothelin. - Wikidata - awgldk - TriplyDB

A novel high-affinity human monoclonal antibody to mesothelin.

A novel high-affinity human monoclonal antibody to mesothelin.

http://www.wikidata.org/entity/Q33634221

about

Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors Mucin-based targeted pancreatic cancer therapy Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin New high affinity monoclonal antibodies recognize non-overlapping epitopes on mesothelin for monitoring and treating mesothelioma Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy.Multifactorial T-cell hypofunction that is reversible can limit the efficacy of chimeric antigen receptor-transduced human T cells in solid tumors In vivo imaging of human malignant mesothelioma grown orthotopically in the peritoneal cavity of nude mice HN125: A Novel Immunoadhesin Targeting MUC16 with Potential for Cancer Therapy Novel immunocytokine IL12-SS1 (Fv) inhibits mesothelioma tumor growth in nude mice.Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signalling and protein synthesis.A novel PET imaging using ⁶⁴Cu-labeled monoclonal antibody against mesothelin commonly expressed on cancer cells Process of hepatic metastasis from pancreatic cancer: biology with clinical significance.Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy The role of mesothelin in tumor progression and targeted therapy.What is recent in pancreatic cancer immunotherapy?A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors.Malignant Peritoneum Mesothelioma with Hepatic Involvement: A Single Institution Experience in 5 Patients and Review of the Literature.A human single-domain antibody elicits potent antitumor activity by targeting an epitope in mesothelin close to the cancer cell surface.Protection of the Furin Cleavage Site in Low-Toxicity Immunotoxins Based on Pseudomonas Exotoxin A.Humanization of high-affinity antibodies targeting glypican-3 in hepatocellular carcinoma Potential targets for pancreatic cancer immunotherapeutics.Immune therapies for malignant mesothelioma.Advances in malignant peritoneal mesothelioma.Oncolytic vaccinia virus as an adjuvant treatment to cytoreductive surgery for malignant peritoneal mesothelioma.2nd PEGS Annual Symposium on Antibodies for Cancer Therapy: April 30-May 1, 2012, Boston, USA.Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models.A re-engineered immunotoxin shows promising preclinical activity in ovarian cancer.Fn3 proteins engineered to recognize tumor biomarker mesothelin internalize upon binding.

P2860

Q26778759-F03721D2-FA80-48E6-A282-66D02CE344C2 Q26861761-7E4093D3-A0F0-45EB-B31F-D96043EDA291 Q27015134-A2077480-E645-4196-A70C-368A82A52E6B Q28547381-CD05158E-4A32-4B84-A765-1B328DD7D187 Q33850265-FB7D3E44-BBE2-4B8E-ABD2-489B6A0EAABA Q34052580-8834B037-103F-4498-BF57-89AC42F89DF7 Q34771909-9F3049B3-7A8E-4E01-A7CE-0ABB4447E8CE Q35001563-28CAEEB7-79FC-4175-A476-2C3A01517E8D Q35049589-A7DE8CEF-E41D-49B1-A180-686A461216A7 Q35170403-9D679752-8C3B-428B-A5F1-2F09A22D2197 Q35323396-DCD88520-D51E-4E44-BBD5-749DD0EEAA58 Q35739397-21DA1A39-2D1D-4674-83FA-CF652700AB42 Q35886496-C224D8C3-5F7C-40EF-8E1F-F078ADC98DF9 Q36597831-4CE5494E-F1CE-4B7C-AE9A-DF5751A4D7D5 Q36665335-9B9144BF-5612-4DF7-A43B-AAF907FA6B80 Q36709308-F69284EF-224F-4F09-AE45-51F74424341F Q36741786-6BD78FA1-EFE0-461A-9EB6-1BE30CE6584B Q36759405-F8798964-BB1C-4DA9-81C1-23B53DBC31BA Q37209001-A762EE33-0BFC-4C6D-8042-5DADE679D822 Q37282388-311E5102-6EAE-433D-96B5-3F78B3B252EC Q37861220-9191A185-A517-40AA-BAE5-7B280254E54D Q38212149-F9D9F5D5-51D3-4910-A0BB-FC75FC34BAD7 Q38261500-F7077554-AF2D-4133-A097-D346B663C85F Q39005715-C29885E0-92A8-4E58-AE29-B551317B94D5 Q42333514-74CE6385-E51E-44BC-9DCE-EB6DDE8BBDDC Q47107902-997625AE-1403-48E6-A3E9-85A67E94B75A Q47128416-1F9DBB60-6AD1-4454-9B88-95419E12B785 Q55257427-7C4E3489-86E6-47A6-A1FB-BCB8C8B2FB10

P2860

A novel high-affinity human monoclonal antibody to mesothelin.

http://www.wikidata.org/entity/Q33634221

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

A novel high-affinity human monoclonal antibody to mesothelin.

@ast

A novel high-affinity human monoclonal antibody to mesothelin.

@en

type

label

A novel high-affinity human monoclonal antibody to mesothelin.

@ast

A novel high-affinity human monoclonal antibody to mesothelin.

@en

prefLabel

A novel high-affinity human monoclonal antibody to mesothelin.

@ast

A novel high-affinity human monoclonal antibody to mesothelin.

@en

P1433

Q33634221-AE11ED39-B4D7-4A72-B23D-4A779366DE8B

P1476

Q33634221-C2984B15-46F2-46C7-8CD9-D88FA26AFD05

P2093

Q33634221-0E6F24BB-6449-443D-BCDC-F21A47934C4B

Q33634221-4FF56B8E-D212-4C84-8EF6-BDC6E94D5BC2

Q33634221-98AFA784-EBBE-4361-9B1C-4F6E34F75935

Q33634221-AA059F61-FA0C-431F-98ED-F0E08EB7D361

P2860

Q33634221-0397BBC7-9CD4-4E2A-A2D9-9343FB3BB0F1

Q33634221-11766723-3A28-4CC9-80EA-35C0C387D8E1

Q33634221-158E57C4-CD0B-49F0-BCB0-F0F11BAD1AB6

Q33634221-1BE29E20-24B5-4050-A503-307920BD0415

Q33634221-2C3FDFFB-6EDB-4FF0-8196-98C2B3F6E772

Q33634221-34D18264-5399-440D-8FD6-8C670787DE06

Q33634221-41E87B39-5BE8-4107-957B-1D1C0AAF99FB

Q33634221-52146B24-F236-4266-A5FF-4175E1E3BFAE

Q33634221-575B6457-DC4C-416E-A816-1F3A34C8CCBF

Q33634221-5F50C76E-2594-4052-8C4B-1A13A47FDB72

P304

Q33634221-A0130496-07CD-45F8-8EA7-B83DCDB6E6FA

P31

Q33634221-C1110B70-C951-4C9F-A81B-3208A70DA11B

P356

Q33634221-C77E675C-161B-4516-90D5-2E9280A22C4D

P433

Q33634221-788A6B68-D06A-4994-A3B6-FAF0FD455F7D

P478

Q33634221-E005EBBD-19CA-4058-BBF5-1E668593B2F0

P50

Q33634221-B7197C07-659F-4267-9D0D-F0C05D8EF6B0

P577

Q33634221-DC2083BA-6917-4F02-9DD8-9C9633B338E7

P5875

Q33634221-160EE88D-F8A4-4C11-B299-EC575D573E62

P698

Q33634221-DD1AFBE7-65EB-4B54-994A-41ADB6CD6795

P921

Q33634221-1925308B-B4F3-475C-91F1-BE2D85EE01F0

P932

Q33634221-CFF53902-238E-4487-8147-630C136318B9

P356

P1433

International Journal of Cancer

P1476

A novel high-affinity human monoclonal antibody to mesothelin

@en

P2093

Ira Pastan

http://www.w3.org/2001/XMLSchema#string

Mingqian Feng

http://www.w3.org/2001/XMLSchema#string

Mitchell Ho

http://www.w3.org/2001/XMLSchema#string

Robert J Fisher

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion

Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers

Reactivity of a monoclonal antibody with human ovarian carcinoma

IMGT, the international ImMunoGeneTics database

Mesothelin targeted cancer immunotherapy

A binding domain on mesothelin for CA125/MUC16

Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors

Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma

A novel human monoclonal antibody that binds with high affinity to mesothelin-expressing cells and kills them by antibody-dependent cell-mediated cytotoxicity.

A recombinant, fully human monoclonal antibody with antitumor activity constructed from phage-displayed antibody fragments.

P304

2020-2030

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.25557

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

128

http://www.w3.org/2001/XMLSchema#string

P50

Christoph Rader

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45200960

http://www.w3.org/2001/XMLSchema#string

P698

20635390

http://www.w3.org/2001/XMLSchema#string

P921

P932

2978266

http://www.w3.org/2001/XMLSchema#string